This poll is based on the session titled “State of Depression” at Psych Congress 2022 by Charles DeBattista, MD, DMH, professor of psychiatry and behavioral sciences and director of the Depression Research...
This poll is based on the session titled “State of Depression” at Psych Congress 2022 by Charles DeBattista, MD, DMH, professor of psychiatry and behavioral sciences and director of the Depression Research...
This poll is based on the session titled “State of Depression” at Psych Congress 2022 by Charles DeBattista, MD, DMH, professor of psychiatry and behavioral sciences and director of the Depression Research...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
The use of social media in medicine is a growing trend worldwide, as it is quick and easy to connect with peers and share knowledge. How do you typically use social media?
The use of social media in medicine is a growing trend worldwide, as it is quick and easy to connect with peers and share knowledge. How do you typically use social media?
Rheumatoid arthritis (RA) treatment often consists of pharmacologic and nonpharmacologic interventions. Which nonpharmacologic intervention has been most helpful to your patients with RA? Let us know by...
